retatrutide phase 2 nejm 2023 obesity trial results vs Ozempic: Clinical Comparisons Weight Regain after Stopping Obesity

-LA has shown promise in diabetes, cardiovascular disease, and metabolic syndrome due to its mitochondrial, anti-inflammatory, and insulin-mimetic effects (23-24)

publicly announced an intent to reclassify roughly 14 of the 19 Category 2 peptides including BPC-157, TB-500, CJC-1295, and thymosin alpha-1 from Category 2 back toward Category 1, which would permit 503A compounding

At 10mcg per dose, 1mg provides roughly 100 doses

Alkaline aminotransferase level of treated rats was not significantly different from those of control distilled water group

By combining science, supervision, and support, GLP-1 therapy provides patients with more than just a toolit offers a system for long-term health improvement